甲状腺微小乳头状癌组织中Bax、nm23蛋白的表达及临床意义

Abstract
Figure/Table
References (20)
Related Citation (9)

Download: PDF (711 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the expression and clinical significance of B lymphocyte tumor associated -2 related X protein (Bax), tumor metastasis suppressor gene 23 (nm23) protein in papillary thyroid microcarcinoma (PTMC) tissues. Methods One hundred and three paraffin specimens of PTMC patients who was given surgery treatment in Haian Affiliated Hospital to Nantong University from May 2016 to May 2017 were selected as observation group, the resection of the tumor was ≥ 5 cm far from paraffin embedded specimens of 103 cases of tumor adjacent tissues selected was as control group, another 100 patients with thyroid adenoma (TA) who was given surgery at the same time were chosen and enrolled as TA group, the expression of Bax and nm23 protein in each group was detected and compared, the relationship between the expression of Bax and nm23 protein and pathological parameters in the observation group was analyzed, and the correlation between Bax and nm23 protein was analyzed. Results The positive expression rates of Bax protein in the observation group and the TA group were significantly higher than the control group, and the differences were statistically significant (P < 0.05). The positive expression rate of nm23 protein in the observation group was significantly higher than the TA group and the control group, and the differences were statistically significant (P < 0.05). The positive expression rates of Bax and nm23 protein in the observation group with lymph node metastasis were significantly lower than without lymph node metastasis, and the differences were statistically significant (P < 0.05). According to the correlation analysis of Spearman, it was found that the expression of Bax was positively correlated with the expression of nm23 protein (r = 0.617, P < 0.05). Conclusion The expression of Bax and nm23 protein in PTMC tissues increased significantly, it is closely related to lymph node metastasis and both two indexes can be used as a monitoring target to evaluate the condition and prognosis of PTMC patients.

Key words： Papillary thyroid microcarcinoma Tissue Bax nm23 protein Expression Clinical significance

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	GU Guiyuan1 WANG Weige2 HUANG Shan3

Cite this article:

GU Guiyuan1 WANG Weige2 HUANG Shan3. Expression and clinical significance of Bax and nm23 protein in papillary thyroid microcarcinoma tissues[J]. 中国医药导报, 2017, 14(36): 29-32.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2017/V14/I36/29

[1] 邓水平，李泉水，陈胜华，等.甲状腺微小乳头状癌的超声特征与颈部淋巴结转移相关因素分析[J].临床超声医学杂志，2017，19（6）：424-426.
[2] 林前煌，徐慧，郇金亮，等.甲状腺微小乳头状癌诊治进展[J].实用肿瘤学杂志，2017，31（1）：61-64.
[3] 代妮娜，张文君.滤泡型甲状腺乳头状癌和经典型甲状腺乳头状癌超声影像对比分析[J].四川医学，2017，38（1）：93-96.
[4] 何坚沃，罗文杰，梁伟彬，等.细针穿刺细胞学检查应用在甲状腺微小乳头状癌诊断中的可行性分析[J].中国当代医药，2017，24（11）：75-77.
[5] 张真真，李青菊.血清促甲状腺激素水平与甲状腺乳头状微小癌的关系[J].山西医药杂志，2017，46（11）：1326-1329.
[6] 闫东.Galectin-3、CK19与HBME-1在甲状腺微小乳头状癌中的表达及临床意义[J].青岛医药卫生，2017，49（4）：298-300.
[7] 刘洋，石铁锋，石臣磊，等.甲状腺微小乳头状癌中央区淋巴结转移危险因素的研究[J].医学临床研究，2017，34（3）：553-555.
[8] 马志斌.甲状腺疾病快速冰冻切片的诊断及鉴别诊断分析[J].中国老年保健医学，2017，15（3）：73-75.
[9] 魏广民，周文波，武伦，等.Bax、nm23蛋白在甲状腺微小乳头状癌的表达及意义[J].实用医学杂志，2017，33（19）：3272-3273.
[10] 吕晓君.甲状腺微小乳头状癌的临床病理观察[J].基层医学论坛，2017，21（1）：83-84.
[11] Qian K，Guo K，Zheng X，et al. Contrastive study of two screening criteria for active surveillance in patients with low-risk papillary thyroid microcarcinoma: a retrospective analysis of 1001 patients [J]. Oncotarget，2017，8（39）：65 836-65 846.
[12] 魏广民，周文波，武伦，等.CyclinD1和Bax在甲状腺微小乳头状癌中的表达及意义[J].重庆医学，2017，46（3）：325-328.
[13] Cvejic D，Selemetjev S，Savin S，et al. Apoptosis and proliferation related molecules （Bcl-2，Bax，p53，PCNA） in papillary microcarcinoma versus papillary carcinoma of the thyroid [J]. Pathology，2008，40（5）：475-480.
[14] 宋小颖.甲状腺乳头状癌Ⅲ区淋巴结转移危险因素分析[J].河南医学研究，2017，26（10）：1813-1814.
[15] 张科.甲状腺微小乳头状癌预后指标的研究[J].实用癌症杂志，2017，32（1）：169-170.
[16] Li M，Zhu XY，Lv J，et al. Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma （CN0）：a study of 273 resections [J]. Eur Rev Med Pharmacol Sci，2017，21（17）：3801-3807.
[17] 许军，丁旭贝，肖光雄，等.甲状腺微小乳头状癌组织中CK19、TPO、Galectin-3和Survivin蛋白表达水平及诊断价值[J].解放军医药杂志，2017，29（6）：48-50.
[18] 吴珠，辛露，常宏，等.甲状腺癌中Bax、Survivin及Livin的表达及意义[J].癌症进展，2017，15（8）：914-916.
[19] Temiz P，Akkas G，Nese N，et al. Determination-of apoptosis and cell cycle modulators （p16，p21，p27，p53，BCL-2，Bax，BCL-xL，and cyclin D1） in thyroid follicular carcinoma，follicular adenoma，and adenomatous nodules via a tissue microarray method [J]. Turk J Med Sci，2015，45（4）：865-871.
[20] Selemetjev SA，Savin SB，Paunovic IR，et al. Changes in the expression pattern of apoptotic molecules （galectin-3，Bcl-2，Bax，survivin） during progression of thyroid malignancy and their clinical significance [J]. Wien Klin Wochenschr，2015，127（9）：337-344.